<DOC>
	<DOCNO>NCT00079872</DOCNO>
	<brief_summary>In study , patient receive either pemetrexed plus irinotecan 5-fluorouracil ( 5-FU ) , leucovorin , irinotecan . The purpose study determine : - How pemetrexed plus irinotecan compare 5-FU , leucovorin , irinotecan term efficacy . - The safety pemetrexed plus irinotecan side effect might associate compare 5-FU , leucovorin , irinotecan . - Whether pemetrexed help patient colorectal cancer .</brief_summary>
	<brief_title>Pemetrexed Plus Comparator Versus Combination 2 Comparators First-Line Treatment Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>The patient must : Histologic cytologic diagnosis adenocarcinoma colon rectum . Performance status 0 2 ECOG Performance Status Scale . Standard postoperative adjuvant radiation therapy rectal cancer allow . Locally advanced metastatic disease . Must 18 year age . The patient must : Received prior chemotherapy advance disease . Prior adjuvant therapy , include 5FU , allow 12 month since last treatment . Received prior treatment irinotecan adjuvant setting . Are unable take vitamin B12 folic acid . Are unable interrupt aspirin , nonsteroidal antiinflammatory drug , COX2 inhibitors 5day period . Have second primary malignancy except carcinoma situ cervix nonmelanomatous skin cancer , unless prior malignancy diagnose definitively treat least 5 year previously subsequent evidence recurrence .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>